BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
about
BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.Associations of MC1R genotype and patient phenotypes with BRAF and NRAS mutations in melanoma.Cutaneous melanoma primary site is linked to nevus density.Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.
P2860
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
@en
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
@nl
type
label
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
@en
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
@nl
prefLabel
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
@en
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
@nl
P2093
P2860
P356
P1476
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
@en
P2093
A I Jimenez-Sanchez
E Gimeno-Carpio
J A Onrubia
Z García-Casado
P2860
P304
P356
10.1111/BJD.13521
P407
P577
2015-03-06T00:00:00Z